AzTrials
AzTrials

AnesthesiaTHConcentrNCT03357900

Closed-loop Anaesthesia for Liver Transplantation: a Pilot Study

A study testing Automated titration of propofol and remifentanil in people with Anesthesia and Liver Transplant, run by Hopital Foch at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Automated titration of propofol and remifentanil guided by the bispectral index (BIS) has been used for numerous surgical procedures. Orthotopic liver transplantation (OLT) uniquely combines major volaemic changes, an anhepatic phase, and ischaemia-reperfusion syndrome. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anesthesia, Liver Transplant
What is being tested?
Automated titration of propofol and remifentanil
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteFrance
Study dates
18 Aug 2010to 9 Feb 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients scheduled for OLT

Who cannot join

  • age younger than 18 years, pregnancy, allergy or hypersensitivity to propofol or remifentanil, a medical history of psychiatric illness, and supraspinal neurological disorders

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hopital Foch

    Suresnes, 92150

Other trials in France

About this study

Automated titration of propofol and remifentanil guided by the bispectral index (BIS) has been used for numerous surgical procedures. Orthotopic liver transplantation (OLT) uniquely combines major volaemic changes, an anhepatic phase, and ischaemia-reperfusion syndrome. We assessed the behaviour of this automated controller during OLT

Being tested
Automated titration of propofol and remifentanil
Keywords
Consciousness Monitor, Clinical Pharmacology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Automated titration of propofol and remifentanilDevice

    Calculation of Consumption of propofol and remifentanil

Study groups in NCT03357900
Study groupRoleWhat they receive
Orthotopic liver transplantationExperimentalNot described
Receives: Device: Automated titration of propofol and remifentanil

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. percentage of time spent in the BIS interval [40-60]

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2017
  2. Study start18 Aug 2010
  3. Primary completion9 Feb 2012
  4. Study completion9 Feb 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03357900
Sponsor's protocol ID
2009/09
Other IDs
2009-A00363-54
Acronym
THConcentr
Status last verified
Nov 2017
First submitted
24 Nov 2017
Last updated
30 Nov 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Automated titration of propofol and remifentanil in people with Anesthesia and Liver Transplant, run by Hopital Foch at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

percentage of time spent in the BIS interval [40-60] (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
THConcentr Clinical Trial NCT03357900 | AzTrials